3

Activated Stat-3 in Melanoma

Année:
2008
Langue:
english
Fichier:
PDF, 532 KB
english, 2008
19

New drugs in gynecologic cancer

Année:
2001
Langue:
english
Fichier:
PDF, 263 KB
english, 2001
23

Histone deacetylase inhibitor induced modulation of anti-estrogen therapy

Année:
2009
Langue:
english
Fichier:
PDF, 1.25 MB
english, 2009
25

Development of histone deacetylase inhibitors for cancer treatment

Année:
2007
Langue:
english
Fichier:
PDF, 427 KB
english, 2007
26

Predictive factor for the response to adjuvant therapy with emphasis in breast cancer

Année:
2001
Langue:
english
Fichier:
PDF, 48 KB
english, 2001
28

ADJUVANT THERAPY FOR RESECTABLE BREAST CANCER

Année:
1999
Langue:
english
Fichier:
PDF, 1.32 MB
english, 1999
32

New protein kinase inhibitors in breast cancer: afatinib and neratinib

Année:
2014
Langue:
english
Fichier:
PDF, 332 KB
english, 2014
33

Role of Taxanes in Adjuvant Therapy

Année:
2000
Langue:
english
Fichier:
PDF, 634 KB
english, 2000
37

Estradiol in Breast Cancer Treatment

Année:
2009
Langue:
english
Fichier:
PDF, 52 KB
english, 2009
38

Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance

Année:
2011
Langue:
english
Fichier:
PDF, 1.44 MB
english, 2011
39

Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy

Année:
2015
Langue:
english
Fichier:
PDF, 1.32 MB
english, 2015
40

Arzoxifene: the development and clinical outcome of an ideal SERM

Année:
2006
Langue:
english
Fichier:
PDF, 372 KB
english, 2006
43

Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors

Année:
2016
Langue:
english
Fichier:
PDF, 1.62 MB
english, 2016
44

Effect of Temporary Ovarian Suppression on Chemotherapy-Induced Amenorrhea, Pregnancy, and Outcome

Année:
2016
Langue:
english
Fichier:
PDF, 98 KB
english, 2016